These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3066491)

  • 41. Halothane-dependent release of intracellular Ca2+ in blood cells in malignant hyperthermia.
    Klip A; Mills GB; Britt BA; Elliott ME
    Am J Physiol; 1990 Mar; 258(3 Pt 1):C495-503. PubMed ID: 2107750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulation and inhibition of [3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs.
    Mickelson JR; Litterer LA; Jacobson BA; Louis CF
    Arch Biochem Biophys; 1990 Apr; 278(1):251-7. PubMed ID: 2321964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dantrolene sodium can increase or attenuate activity of skeletal muscle ryanodine receptor calcium release channel. Clinical implications.
    Nelson TE; Lin M; Zapata-Sudo G; Sudo RT
    Anesthesiology; 1996 Jun; 84(6):1368-79. PubMed ID: 8669678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced inhibitory effect of Mg2+ on ryanodine receptor-Ca2+ release channels in malignant hyperthermia.
    Laver DR; Owen VJ; Junankar PR; Taske NL; Dulhunty AF; Lamb GD
    Biophys J; 1997 Oct; 73(4):1913-24. PubMed ID: 9336187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
    MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
    Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant hyperthermia: molecular defects in membrane permeability.
    Cheah KS; Cheah AM
    Experientia; 1985 May; 41(5):656-61. PubMed ID: 3888661
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ca2+ release channels of pigs heterozygous for malignant hyperthermia.
    Shomer NH; Mickelson JR; Louis CF
    Muscle Nerve; 1995 Oct; 18(10):1167-76. PubMed ID: 7659111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deficient function of the sarcoplasmic reticulum in patients susceptible to malignant hyperthermia.
    Condrescu M; López JR; Medina P; Alamo L
    Muscle Nerve; 1987; 10(3):238-41. PubMed ID: 2951595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignant hyperthermia in dogs.
    Nelson TE
    J Am Vet Med Assoc; 1991 Mar; 198(6):989-94. PubMed ID: 2032926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiac and muscle fatigue due to relative functional overload induced by excessive stimulation, hypersensitive excitation-contraction coupling, or diminished performance capacity correlates with sarcoplasmic reticulum failure.
    O'Brien PJ; Shen H; Weiler J; Ianuzzo CD; Wittnich C; Moe GW; Armstrong PW
    Can J Physiol Pharmacol; 1991 Feb; 69(2):262-8. PubMed ID: 2054742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of calmodulin antagonist drugs on isolated sarcoplasmic reticulum from malignant hyperpyrexia susceptible swine.
    Collins SP; White MD; Denborough MA
    Int J Biochem; 1987; 19(9):819-26. PubMed ID: 2961633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium regulation by skeletal muscle membranes of horses with recurrent exertional rhabdomyolysis.
    Ward TL; Valberg SJ; Gallant EM; Mickelson JR
    Am J Vet Res; 2000 Mar; 61(3):242-7. PubMed ID: 10714513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of extracellular magnesium on myoplasmic [Ca2+] in malignant hyperthermia susceptible swine.
    Lopez JR; Sanchez V; Lopez I; Ryan JF; Mendoza M; Sreter FA; Allen PD
    Anesthesiology; 1990 Jul; 73(1):109-17. PubMed ID: 2360720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of propofol on Ca2+ regulation by malignant hyperthermia-susceptible muscle membranes.
    Fruen BR; Mickelson JR; Roghair TJ; Litterer LA; Louis CF
    Anesthesiology; 1995 May; 82(5):1274-82. PubMed ID: 7741303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the halothane-sensitivity gene on sarcoplasmic reticulum function.
    Mickelson JR; Gallant EM; Rempel WE; Johnson KM; Litterer LA; Jacobson BA; Louis CF
    Am J Physiol; 1989 Oct; 257(4 Pt 1):C787-94. PubMed ID: 2801927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrasound Elastography for Rapid, Real-time Detection of Localized Muscular Reaction in Malignant Hyperthermia-susceptible Pigs.
    Johannsen S; Türkmeneli I; Isbary S; Roewer N; Schuster F
    Anesthesiology; 2018 Nov; 129(5):989-999. PubMed ID: 30204593
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal action potential responses to halothane in heart muscle isolated from malignant hyperthermia-susceptible pigs.
    Roewer N; Greim C; Rumberger E; Schulte am Esch J
    Anesthesiology; 1995 Apr; 82(4):947-53. PubMed ID: 7717567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abnormal uptake and release of Ca2+ ions from human malignant hyperthermia-susceptible sarcoplasmic reticulum.
    O'Sullivan GH; McIntosh JM; Heffron JJ
    Biochem Pharmacol; 2001 Jun; 61(12):1479-85. PubMed ID: 11377377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Electrophoresis of muscle proteins is not a method for diagnosis of malignant hyperthermia susceptibility.
    Walsh MP; Brownell AK; Littmann V; Paasuke RT
    Anesthesiology; 1986 Apr; 64(4):473-9. PubMed ID: 3963453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.